GROUNDTH Trademark

Trademark Overview


On Wednesday, January 8, 2020, a trademark application was filed for GROUNDTH with the United States Patent and Trademark Office. The USPTO has given the GROUNDTH trademark a serial number of 88750545. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2023. This trademark is owned by Eli Lilly and Company. The GROUNDTH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
groundth

General Information


Serial Number88750545
Word MarkGROUNDTH
Filing DateWednesday, January 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU EXTENSION 5 GRANTED
Monday, October 10, 2022SOU EXTENSION 5 FILED
Monday, October 10, 2022SOU TEAS EXTENSION RECEIVED
Saturday, April 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 31, 2022SOU EXTENSION 4 GRANTED
Thursday, March 31, 2022SOU EXTENSION 4 FILED
Thursday, March 31, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 12, 2021SOU EXTENSION 3 GRANTED
Thursday, October 7, 2021SOU EXTENSION 3 FILED
Thursday, October 7, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 22, 2021SOU EXTENSION 2 GRANTED
Thursday, April 22, 2021SOU EXTENSION 2 FILED
Thursday, April 22, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 1 GRANTED
Monday, October 26, 2020SOU EXTENSION 1 FILED
Thursday, November 5, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 26, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 10, 2020ASSIGNED TO EXAMINER
Saturday, January 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 11, 2020NEW APPLICATION ENTERED